Detalles de la búsqueda
1.
Pharmacotherapy in paediatric heart failure: a Delphi process.
Cardiol Young
; 29(7): 869-876, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31230601
2.
Predicting Stereoselective Disposition of Carvedilol in Adult and Pediatric Chronic Heart Failure Patients by Incorporating Pathophysiological Changes in Organ Blood Flows-A Physiologically Based Pharmacokinetic Approach.
Drug Metab Dispos
; 44(7): 1103-15, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27068272
3.
Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years.
J Pain Res
; 15: 3103-3114, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203787
4.
Physiologically based pharmacokinetic modeling: methodology, applications, and limitations with a focus on its role in pediatric drug development.
J Biomed Biotechnol
; 2011: 907461, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21716673
5.
Outcomes of the Pediatric Development Plan of Tapentadol.
J Pain Res
; 14: 249-261, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33542654
6.
Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old.
J Pain Res
; 13: 3107-3123, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33262645
7.
Relative Bioavailability of Enalapril Administered as Orodispersible Minitablets in Healthy Adults.
Clin Pharmacol Drug Dev
; 9(2): 203-213, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31411383
8.
Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: a European survey.
BMJ Paediatr Open
; 3(1): e000365, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815586
9.
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.
Clin Pharmacol Ther
; 104(1): 88-110, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315504
10.
Optimizing the Clinical Use of Carvedilol in Liver Cirrhosis Using a Physiologically Based Pharmacokinetic Modeling Approach.
Eur J Drug Metab Pharmacokinet
; 42(3): 383-396, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27313074
11.
A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
Clin Pharmacokinet
; 54(9): 943-62, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773479
12.
Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
AAPS J
; 16(2): 226-39, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24399240
13.
Question 1: How safe are ACE inhibitors for heart failure in children?
Arch Dis Child
; 103(1): 106-109, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074732
14.
Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows.
Clin Pharmacokinet
; 55(1): 139-41, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26649872
Resultados
1 -
14
de 14
1
Próxima >
>>